Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma

BACKGROUND: Although immunotherapy has been considered as a potent strategy for lung adenocarcinoma (LUAD), only a small part of patients was served as potentially clinical benefiters. Immunogenic cell death (ICD), a type of regulated cell death (RCD), which enable to reshape the tumor immune microe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yingshu, Li, Yi, Long, Shan, Xu, Yuanyuan, Liu, Xinxin, Sun, Zhijia, Sun, Yuanyuan, Hu, Jia, Li, Xiaosong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410984/
https://www.ncbi.nlm.nih.gov/pubmed/37553698
http://dx.doi.org/10.1186/s12920-023-01604-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410984/
https://www.ncbi.nlm.nih.gov/pubmed/37553698
http://dx.doi.org/10.1186/s12920-023-01604-w

Ejemplares similares